Lipoteichoic acid from Staphylococcus aureus induced expression of MMP-9 in human middle ear epithelial cells

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 4, 2012, Pages 475-479

  Park, Hun Yi ^a   Song, Jung Whan ^a   Hong, Sung Pyo ^a   In, Seung Min ^b   Kim, Hyun Jun ^a  

^a Ajou University School of Medicine   (South Korea)

^b Konyang University   (South Korea)

Author keywords

Matrix metalloproteinase; Middle ear; Otitis media

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LIPOTEICHOIC ACID; MATRILYSIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME RELEASE; EPITHELIUM CELL; FATTY ACID ANALYSIS; HUMAN; HUMAN CELL; MIDDLE EAR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

CELL CULTURE TECHNIQUES; EAR, MIDDLE; EPITHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; OTITIS MEDIA; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84862795875     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.12.028     Document Type: Article

References (20)

1. Bluestone C.D., Klein J.O. Otitis media, atelectasis, and eustacian tube dysfunction. Pediatric Otolaryngology 1996, 388-582. WB Saunders Co., Philadelphia, PA. C.D. Bluestone, S.E. Stool, M.A. Kenna (Eds.).
2. Hall-Stoodley L., Hu F.Z., Gieseke A., Nistico L., Nguyen D., Hayes J., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006, 296(2):202-211.
3. Cavaillon J.M., Adib-Conquy M., Fitting C., Adrie C., Payen D. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 2003, 35:535-544.
4. Morath S., von Aulock S., Hartung T. Structure/function relationships of lipoteichoic acids. J. Endotoxin Res. 2005, 11:348-356.
5. Souza L.F., Jardim F.R., Sauter I.P., Souza M.M., Barreto F., Margis R., et al. Lipoteichoic acid from Staphylococcus aureus increases matrix metalloproteinase 9 expression in RAW264.7 macrophages: modulation by A2A and A2B adenosine receptors. Mol. Immunol. 2009, 46(5):937-942.
6. Parks W.C., Wilson C.L., Lopez-Boado Y.S. Matrixmetalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 2004, 4:617-629.
7. Moon S.K., Linthicum F.H., Yang H.D., Lee S.J., Park K. Activities of matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in idiopathic hemotympanum and otitis media with effusion. Acta Otolaryngol. 2008, 128(2):144-150.
8. Jang C.H., Shin S.H., Cho H.H., Moon S.J., Cho Y.B. Expression of matrix metalloproteinase-9 and -2 in pediatric chronic otitis media with effusion. Int. J. Pediatr. Otorhinolaryngol. 2006, 70(July (7)):1155-1158.
9. Han S.H., Kim J.H., Seo H.S., Martin M.H., Chung G.H., Michalek S.M., et al. Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2. J. Immunol. 2006, 176:573-579.
10. Norlander T., Westrin K.M., Stierna P. The inflammatory response of the sinus and nasal mucosa during sinusitis: implications for research and therapy. Acta Otolaryngol. Suppl. 1994, 515:38-44.
11. Sriskandan S., Cohen J. Gram-positive sepsis. Mechanisms and differences from Gram-negative sepsis. Infect. Dis. Clin. North Am. 1999, 13:397-412.
12. Morath S., Geyer A., Spreitzer I., Hermann C., Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 2002, 70:938-944.
13. Wysocki A.B., Staiano-Coico L., Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 1993, 101:64-68.
14. Mast B.A., Schultz G.S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996, 4:411-420.
15. Watelet J.B., Bachert C., Claeys C., Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004, 59:54-60.
16. Belleguic C., Corbel M., Germain N., Lena H., Boichot E., Delaval P.H., et al. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin. Exp. Allergy 2002, 32:217-223.
17. Vonk M.J., Hiemstra P.S., Grote J.J. An antimicrobial peptide modulates epithelial responses to bacterial products. Laryngoscope 2008, 118(5):816-820.
18. Kita H., Himi T. Cytokine and chemokine induction using cell wall component and toxin derived from Gram-positive bacteria in the rat middle ear. Acta Otolaryngol. 1999, 119(4):446-452.
19. Jennings C.R., Guo L., Collins H.M., Birchall J.P. Matrix metalloproteinases 2 and 9 in otitis media with effusion. Clin. Otolaryngol. Allied Sci. 2001, 26(December (6)):491-494.
20. Antonelli P.J., Schultz G.S., Kim K.M., Cantwell J.S., Sundin D.J., Pemberton P.A., et al. Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions. Laryngoscope 2003, 113(August (8)):1347-1351.